Jacques Izopet

34.4k total citations · 7 hit papers
530 papers, 22.3k citations indexed

About

Jacques Izopet is a scholar working on Hepatology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Jacques Izopet has authored 530 papers receiving a total of 22.3k indexed citations (citations by other indexed papers that have themselves been cited), including 307 papers in Hepatology, 280 papers in Infectious Diseases and 190 papers in Epidemiology. Recurrent topics in Jacques Izopet's work include Hepatitis Viruses Studies and Epidemiology (171 papers), Hepatitis C virus research (158 papers) and Liver Disease and Transplantation (138 papers). Jacques Izopet is often cited by papers focused on Hepatitis Viruses Studies and Epidemiology (171 papers), Hepatitis C virus research (158 papers) and Liver Disease and Transplantation (138 papers). Jacques Izopet collaborates with scholars based in France, United States and United Kingdom. Jacques Izopet's co-authors include Nassim Kamar, Florence Abravanel, Lionel Rostaing, Jean‐Michel Mansuy, Karine Sauné, Harry R. Dalton, Sébastien Lhomme, Christophe Pasquier, Martine Dubois and Jean‐Marie Péron and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Jacques Izopet

520 papers receiving 21.9k citations

Hit Papers

Hepatitis E Virus and Chr... 2008 2026 2014 2020 2008 2012 2021 2014 2017 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Hepatitis E Virus and Chronic Hepatitis in Organ-Transplant Recipients
    2008 965 citations Nassim Kamar, Jean‐Michel Mansuy et al. profile →
  2. Hepatitis E
    2012 675 citations Nassim Kamar, Florence Abravanel et al. profile →
  3. Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
    2021 510 citations Nassim Kamar, Florence Abravanel et al. profile →
  4. Hepatitis E Virus Infection
    2014 483 citations Nassim Kamar, Florence Abravanel et al. profile →
  5. Hepatitis E virus infection
    2017 396 citations Nassim Kamar, Jacques Izopet et al. profile →
  6. Insertions and Duplications in the Polyproline Region of the Hepatitis E Virus
    2020 353 citations Sébastien Lhomme, Florence Nicot et al. profile →
  7. Proposed reference sequences for hepatitis E virus subtypes
    2016 321 citations Jacques Izopet et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jacques Izopet 14.9k 12.4k 6.2k 3.4k 1.1k 530 22.3k
Richard S. Tedder 4.4k 0.3× 5.2k 0.4× 6.1k 1.0× 2.6k 0.8× 168 0.2× 297 12.4k
Hubert G.M. Niesters 4.1k 0.3× 4.9k 0.4× 8.5k 1.4× 1.0k 0.3× 84 0.1× 304 14.3k
Harold S. Margolis 11.8k 0.8× 6.7k 0.5× 10.8k 1.7× 391 0.1× 193 0.2× 198 19.8k
Jean‐Michel Molina 1.3k 0.1× 11.4k 0.9× 5.9k 0.9× 7.2k 2.1× 160 0.1× 547 18.7k
Mark J. DiNubile 2.9k 0.2× 4.6k 0.4× 4.7k 0.8× 1.1k 0.3× 315 0.3× 160 9.2k
Lindsey R. Baden 985 0.1× 5.9k 0.5× 5.0k 0.8× 700 0.2× 361 0.3× 230 10.7k
Maria Rosaria Capobianchi 1.6k 0.1× 4.6k 0.4× 2.8k 0.5× 1.6k 0.5× 81 0.1× 396 9.5k
Robert L. Atmar 1.7k 0.1× 12.9k 1.0× 5.3k 0.9× 433 0.1× 154 0.1× 270 19.4k
Mel Krajden 3.5k 0.2× 3.5k 0.3× 8.4k 1.4× 509 0.1× 22 0.0× 367 11.8k
Yong Poovorawan 4.3k 0.3× 6.0k 0.5× 8.2k 1.3× 210 0.1× 119 0.1× 763 15.4k

Countries citing papers authored by Jacques Izopet

Since Specialization
Citations

This map shows the geographic impact of Jacques Izopet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Izopet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Izopet more than expected).

Fields of papers citing papers by Jacques Izopet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Izopet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Izopet. The network helps show where Jacques Izopet may publish in the future.

Co-authorship network of co-authors of Jacques Izopet

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques Izopet. A scholar is included among the top collaborators of Jacques Izopet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques Izopet. Jacques Izopet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pasquier, Christophe, et al.. (2024). HPV genotyping in clinical samples using long‐read single‐molecule real‐time sequencing. Journal of Medical Virology. 96(5). e29652–e29652. 2 indexed citations
2.
Raymond, Stéphanie, et al.. (2024). Comparison of short‐read and long‐read next‐generation sequencing technologies for determining HIV‐1 drug resistance. Journal of Medical Virology. 96(10). e29951–e29951. 1 indexed citations
3.
Prudhomme, Thomas, Chloé Couat, Arnaud Del Bello, et al.. (2024). BK Viremia and Viruria Does Not Depend on the Type of Double-J Stent Used During Kidney Transplantation.. Experimental and Clinical Transplantation. 22(4). 267–269. 1 indexed citations
4.
Bello, Arnaud Del, F. Sallusto, Audrey Delas, et al.. (2024). Effect of steroid pulses in severe BK virus allograft nephropathy with extensive interstitial inflammation. Transplant Infectious Disease. 26(2). e14260–e14260. 1 indexed citations
5.
Dimeglio, Chloé, et al.. (2023). Weaker Effects of the Fourth Dose of BNT162b2 SARS-CoV-2 Vaccine on the Elderly Human Population. Vaccines. 11(6). 1095–1095. 1 indexed citations
6.
Kamar, Nassim, Florence Abravanel, Olivier Marion, et al.. (2022). Anti-SARS-CoV-2 spike protein and neutralizing antibodies at 1 and 3 months after three doses of SARS-CoV-2 vaccine in a large cohort of solid organ transplant patients. American Journal of Transplantation. 22(5). 1467–1474. 29 indexed citations
7.
Kamar, Nassim, Arnaud Del Bello, Florence Abravanel, Qiuwei Pan, & Jacques Izopet. (2022). Unmet Needs for the Treatment of Chronic Hepatitis E Virus Infection in Immunocompromised Patients. Viruses. 14(10). 2116–2116. 4 indexed citations
8.
Martin, Hélène, Yann Aubert, Jean‐Michel Mansuy, et al.. (2022). Human Cytomegalovirus Modifies Placental Small Extracellular Vesicle Composition to Enhance Infection of Fetal Neural Cells In Vitro. Viruses. 14(9). 2030–2030. 6 indexed citations
9.
Marion, Olivier, Arnaud Del Bello, Florence Abravanel, et al.. (2021). Safety and Immunogenicity of Anti–SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants. Annals of Internal Medicine. 174(9). 1336–1338. 92 indexed citations
10.
Bello, Arnaud Del, Florence Abravanel, Laurent Alric, et al.. (2019). No evidence of occult hepatitis C or E virus infections in liver‐transplant patients with sustained virological response after therapy with direct acting agents. Transplant Infectious Disease. 21(4). e13093–e13093. 4 indexed citations
11.
Lambert-Niclot, Sidonie, Jean‐Luc Meynard, Anne‐Geneviève Marcelin, et al.. (2018). Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies. Clinical Infectious Diseases. 67(12). 1883–1889. 3 indexed citations
12.
Hirsch, Hans H., Catherine Mengelle, Laure Esposito, et al.. (2018). Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation. Transplant Infectious Disease. 20(4). e12917–e12917. 16 indexed citations
13.
Wychowski, Czeslaw, Ibrahim M. Sayed, Jean‐Christophe Meunier, et al.. (2018). Hepatitis E virus lifecycle and identification of 3 forms of the ORF2 capsid protein. Journal of Hepatology. 68. S781–S782. 4 indexed citations
14.
Sayed, Ibrahim M., Lieven Verhoye, Laurence Cocquerel, et al.. (2016). Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver. Gut. 66(5). 920–929. 106 indexed citations
15.
16.
Rostaing, Lionel, Karine Sauné, Laurence Lavayssière, et al.. (2011). Tenofovir Therapy in Hepatitis B Virus-Positive Solid-Organ Transplant Recipients. Transplantation. 91(8). 916–920. 32 indexed citations
17.
Izopet, Jacques, Nassim Kamar, Florence Abravanel, et al.. (2009). L’hépatite E chronique. Virologie. 13(6). 317–325.
18.
Abravanel, Florence & Jacques Izopet. (2008). Recombinaison génétique et virus de l’hépatite C. Virologie. 12(1). 7–14. 1 indexed citations
19.
Descamps, Diane, Vincent Cálvez, Jacques Izopet, et al.. (2001). Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide study. AIDS. 15(14). 1777–1782. 30 indexed citations
20.
Izopet, Jacques, Karine Sauné, G. Salama, et al.. (2001). Infections nosocomiales à VHC en hémodialyse. Annales de biologie clinique. 59(5). 7–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard S. Tedder Breakdown of academic impact, for papers by Hubert G.M. Niesters Breakdown of academic impact, for papers by Harold S. Margolis Breakdown of academic impact, for papers by Jean‐Michel Molina Breakdown of academic impact, for papers by Mark J. DiNubile Breakdown of academic impact, for papers by Lindsey R. Baden Breakdown of academic impact, for papers by Maria Rosaria Capobianchi Breakdown of academic impact, for papers by Robert L. Atmar Breakdown of academic impact, for papers by Mel Krajden Breakdown of academic impact, for papers by Yong Poovorawan
Rankless by CCL
2026